Learning outcomes
By the end of this lesson you should be able to: state the two questions that separate a platelet bleeding disorder from a coagulation factor disorder and the bedside features of each; interpret a bleeding time, a prothrombin time and an activated partial thromboplastin time in combination; distinguish haemophilia A from haemophilia B from von Willebrand disease by the pattern of tests; explain why haemophilia A and von Willebrand disease overlap and why they are treated differently; name the four classes of anticoagulant and antiplatelet drug and their mechanism; and describe the features of disseminated intravascular coagulation.
Prerequisites
Lesson 10 (haemostasis and coagulation), because the tests are named after the pathway they measure.
The big idea
The two patterns are the most useful distinction in the whole of haematology, and they come from the structure of the clot itself. Primary haemostasis is the bail of platelets, which holds the small vessels of the skin and the mucosa; when it fails, those vessels bleed, and the bleeding is immediate and superficial. Secondary haemostasis is the fibrin mesh, which is what holds a large injury sealed long enough to heal; when it fails, deep tissues bleed, and the bleeding is delayed and relentless.
| Question | Platelet (primary) disorder | Coagulation (secondary) disorder |
|---|---|---|
| Where does it bleed? | Superficial — the skin and the mucosa | Deep — joints, muscles and the retroperitoneum |
| When after injury | Immediately | Delayed, hours later |
| Classic presentation | Purpura, epistaxis, gum bleeding, menorrhagia | Haemarthrosis, muscle haematoma, bleeding days after dental extraction |
| Typical disorders | Thrombocytopenia, aspirin and clopidogrel, von Willebrand disease, uraemia | Haemophilia A and B, warfarin and heparin, vitamin K deficiency, disseminated intravascular coagulation |
| Clotting tests | Normal PT and APTT | Prolonged PT, APTT or both |
Worked example: reading the tests as a set
No single test diagnoses anything on its own; the pattern does. The full set is a platelet count, a bleeding time or platelet function test, a prothrombin time, an activated partial thromboplastin time, a thrombin time and a fibrinogen level.
| Disorder | Platelet count | Bleeding time | PT | APTT | Interpretation |
|---|---|---|---|---|---|
| Thrombocytopenia | Low | Prolonged | Normal | Normal | A platelet problem: too few platelets to form a plug |
| Aspirin effect | Normal | Prolonged | Normal | Normal | The platelets are present but cannot aggregate |
| Haemophilia A or B | Normal | Normal | Normal | Prolonged | An intrinsic pathway factor deficiency |
| von Willebrand disease | Normal | Prolonged | Normal | Prolonged | The factor VIII carrier is missing, so factor VIII is short, and platelets cannot adhere |
| Warfarin therapy | Normal | Normal | Prolonged | Prolonged | The vitamin K dependent factors are suppressed |
| Liver failure | Low | Prolonged | Prolonged | Prolonged | A failure of synthesis and of clearance |
| Disseminated intravascular coagulation | Low | Prolonged | Prolonged | Prolonged | Consumption of platelets, factors and fibrinogen |
Notevon Willebrand disease is the interesting row, because it prolongs both the bleeding time and the APTT. It is a platelet adhesion defect, since von Willebrand factor is what bridges collagen to the platelet, and it also lowers factor VIII, since von Willebrand factor carries it. That double signature is what separates it from haemophilia, whose APTT is prolonged but whose platelet function is entirely normal.
Haemophilia A and B
Both haemophilias prolong the APTT and leave the prothrombin time normal, because the defect is on the intrinsic side of the cascade; the platelet count and the bleeding time are also normal, so the platelet plug forms — which is exactly why the bleeding is delayed until the day after a dental extraction rather than at the moment of injury. Treatment is replacement of the missing factor, given prophylactically in severe disease and on demand after injury, and the recombinant concentrates have removed the infection risk of pooled plasma.
The drugs
| Drug | Mechanism | Monitored by | Reversed by |
|---|---|---|---|
| Unfractionated heparin | Potentiates antithrombin, which inactivates thrombin and factor Xa | The APTT, or the anti-Xa assay | Protamine sulfate |
| Low molecular weight heparin | Mostly potentiates antithrombin against factor Xa only | Anti-Xa activity, mainly in renal impairment or pregnancy | Protamine, but only partially |
| Warfarin | Inhibits vitamin K epoxide reductase, blocking the carboxylation of factors II, VII, IX and X and proteins C and S | The prothrombin time, reported as the INR | Vitamin K, and fresh frozen plasma or prothrombin complex concentrate if urgent |
| Direct oral anticoagulants | Either thrombin inhibitors or factor Xa inhibitors | No routine test; the anti-Xa assay for Xa inhibitors | Andexanet alfa for the Xa inhibitors, and idarucizumab for the factor IIa inhibitor dabigatran |
| Aspirin | Irreversibly blocks the cyclooxygenase that makes thromboxane A2, inhibiting platelet aggregation | Not monitored; risk of a platelet function problem | New platelets, not a drug |
| Clopidogrel | Blocks the P2Y12 receptor, the final common pathway of platelet activation | Not monitored | New platelets, and time |
NoteAspirin's effect lasts seven to ten days because the inhibition is irreversible, and a platelet cannot make new cyclooxygenase — it has no nucleus. That is the reason for the seven-day gap before surgery in a patient taking it, and the same reasoning applies to any antiplatelet drug.
Worked example: disseminated intravascular coagulation
Disseminated intravascular coagulation is the one condition in which everything is consumed at once. Widespread activation of coagulation generates microthrombi that obstruct small vessels, while the platelets and the clotting factors used to build them are used up, and the fibrinolysis that follows degrades the fibrin.
| Feature | Mechanism |
|---|---|
| Bleeding from puncture sites and clinical bleeding | Consumption of platelets, factors V and VIII and fibrinogen |
| Schistocytes on the blood film | Microangiopathic haemolysis as red cells are sheared across fibrin strands in small vessels |
| Thrombosis of small vessels producing organ failure | Fibrin deposition in the microcirculation |
| Low platelets and a low fibrinogen with prolonged times | Consumption, and the raised D-dimer from fibrin breakdown |
Watch outDisseminated intravascular coagulation is treated by treating the cause — usually sepsis, trauma, obstetric catastrophe or malignancy — and by replacing what has been consumed. It is not treated with an anticoagulant alone, and it is not treated with heparin except in very specific circumstances.
Common mistakes
Watch outSaying a normal platelet count excludes a bleeding disorder. Von Willebrand disease and a platelet function defect both give normal counts with a prolonged bleeding time. It is the function, not the number, that is at fault.
Watch outTreating disseminated intravascular coagulation with heparin. The bleeding of DIC comes from consumption, so the treatment is replacement of what is consumed and treatment of the underlying cause — not anticoagulation.
Watch outForgetting that von Willebrand disease lowers factor VIII, so its treatment is desmopressin or von Willebrand factor concentrate rather than a pure factor VIII concentrate — and this is a difference of real clinical consequence.
Check your understanding
How do you distinguish a primary from a secondary haemostatic failure at the bedside, without a single laboratory result?
Why does haemophilia A prolong the APTT and leave the prothrombin time normal, while warfarin prolongs both?
State the mechanism and the monitoring test for each of unfractionated heparin, warfarin and aspirin.
Multiple choice
Which pattern of bleeding indicates a defect of the coagulation factors rather than of the platelets?
Which finding is NOT part of disseminated intravascular coagulation?
Which drug's effect can be reversed with protamine?
Which statement about haemophilia A is correct?
Which laboratory pattern characterises von Willebrand disease?
A patient taking an anticoagulant has a normal prothrombin time and a normal APTT. Which drug has this profile?
Summary and next
The tests are named after the pathway they measure, and the pattern they make together localises the defect: a prolonged APTT alone points to the intrinsic pathway, a prolonged PT alone to the extrinsic, and both to the common pathway or to a global loss of factors. Bleeding patterns predict the category — superficial and immediate for platelets, deep and delayed for factors — and the drugs map onto the same three points of haemostasis, heparin on antithrombin, warfarin on the vitamin K dependent factors, and the antiplatelet agents on platelet activation.
Next: allergy, autoimmunity and immunodeficiency — the failures, rather than the successes, of the system you met in the last lesson.